These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 1329637)

  • 1. Pharmacokinetics and tissue penetration of tazobactam and piperacillin in patients undergoing colorectal surgery.
    Kinzig M; Sörgel F; Brismar B; Nord CE
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1997-2004. PubMed ID: 1329637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic characteristics of piperacillin/tazobactam.
    Sörgel F; Kinzig M
    Intensive Care Med; 1994 Jul; 20 Suppl 3():S14-20. PubMed ID: 7962984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of piperacillin and tazobactam in plasma and subcutaneous interstitial fluid in critically ill patients receiving continuous venovenous haemodiafiltration.
    Varghese JM; Jarrett P; Boots RJ; Kirkpatrick CM; Lipman J; Roberts JA
    Int J Antimicrob Agents; 2014 Apr; 43(4):343-8. PubMed ID: 24612982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.
    Jehl F; Muller-Serieys C; de Larminat V; Monteil H; Bergogne-Berezin E
    Antimicrob Agents Chemother; 1994 Dec; 38(12):2780-4. PubMed ID: 7695262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.
    Nau R; Kinzig-Schippers M; Sörgel F; Schinschke S; Rössing R; Müller C; Kolenda H; Prange HW
    Antimicrob Agents Chemother; 1997 May; 41(5):987-91. PubMed ID: 9145857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-dose pharmacokinetics of piperacillin and tazobactam in patients with renal disease.
    Johnson CA; Halstenson CE; Kelloway JS; Shapiro BE; Zimmerman SW; Tonelli A; Faulkner R; Dutta A; Haynes J; Greene DS
    Clin Pharmacol Ther; 1992 Jan; 51(1):32-41. PubMed ID: 1310077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.
    Wise R; Logan M; Cooper M; Andrews JM
    Antimicrob Agents Chemother; 1991 Jun; 35(6):1081-4. PubMed ID: 1656853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam.
    Sörgel F; Kinzig M
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():39-60. PubMed ID: 8383655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetics and pharmacodynamics of piperacillin/tazobactam in patients with complicated intra-abdominal infection.
    Li C; Kuti JL; Nightingale CH; Mansfield DL; Dana A; Nicolau DP
    J Antimicrob Chemother; 2005 Aug; 56(2):388-95. PubMed ID: 16002420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Pharmacokinetics and Pharmacodynamics of Extended-Infusion Piperacillin and Tazobactam in Critically Ill Children.
    Nichols K; Chung EK; Knoderer CA; Buenger LE; Healy DP; Dees J; Crumby AS; Kays MB
    Antimicrob Agents Chemother; 2016 Jan; 60(1):522-31. PubMed ID: 26552978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis.
    Tomaselli F; Dittrich P; Maier A; Woltsche M; Matzi V; Pinter J; Nuhsbaumer S; Pinter H; Smolle J; Smolle-Jüttner FM
    Br J Clin Pharmacol; 2003 Jun; 55(6):620-4. PubMed ID: 12814459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Penetration of piperacillin-tazobactam into cancellous and cortical bone tissues.
    Incavo SJ; Ronchetti PJ; Choi JH; Wu H; Kinzig M; Sörgel F
    Antimicrob Agents Chemother; 1994 Apr; 38(4):905-7. PubMed ID: 8031071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin-tazobactam.
    Kim MK; Capitano B; Mattoes HM; Xuan D; Quintiliani R; Nightingale CH; Nicolau DP
    Pharmacotherapy; 2002 May; 22(5):569-77. PubMed ID: 12013355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ex vivo pharmacodynamic study of piperacillin alone and in combination with tazobactam, compared with ticarcillin plus clavulanic acid.
    Van der Auwera P; Duchateau V; Lambert C; Husson M; Kinzig M; Sörgel F
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1860-8. PubMed ID: 8239597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penetration of piperacillin/tazobactam (4 g/500 mg) into synovial tissue.
    Boselli E; Breilh D; Debon R; Duflo F; Bel JC; Saux MC; Chassard D; Allaouchiche B
    J Chemother; 2002 Feb; 14(1):54-8. PubMed ID: 11892900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrapulmonary penetration of ceftolozane/tazobactam and piperacillin/tazobactam in healthy adult subjects.
    Chandorkar G; Huntington JA; Gotfried MH; Rodvold KA; Umeh O
    J Antimicrob Chemother; 2012 Oct; 67(10):2463-9. PubMed ID: 22773741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients.
    Roger C; Cotta MO; Muller L; Wallis SC; Lipman J; Lefrant JY; Roberts JA
    Int J Antimicrob Agents; 2017 Aug; 50(2):227-231. PubMed ID: 28689876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and tissue penetration of piperacillin/tazobactam with particular reference to its potential in abdominal and soft tissue infections.
    Sörgel F; Kinzig M
    Eur J Surg Suppl; 1994; (573):39-44. PubMed ID: 7524794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of piperacillin-tazobactam in human jaw and hip bone.
    Al-Nawas B; Kinzig-Schippers M; Soergel F; Shah PM
    J Craniomaxillofac Surg; 2008 Dec; 36(8):468-72. PubMed ID: 18783957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of tazobactam M1 metabolite after administration of piperacillin/tazobactam in subjects with renal impairment.
    Halstenson CE; Wong MO; Johnson CA; Zimmerman SW; Onorato JJ; Keane WF; Doepner M; Sia L; Tantillo K; Bansal S
    J Clin Pharmacol; 1994 Dec; 34(12):1208-17. PubMed ID: 7738217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.